Related Experiment Video
Updated: Apr 28, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Prediction of pediatric bipolar disorder using neuroanatomical signatures of the amygdala
Benson Mwangi1, Danielle Spiker, Giovana B Zunta-Soares
1Department of Psychiatry and Behavioral Sciences, University of Texas Center of Excellence on Mood Disorders, UT Houston Medical School, Houston, TX, USA.
Insights
Researchers identified structural brain differences in the amygdala to help diagnose pediatric bipolar disorder (PBD). This neuroimaging approach achieved 78% accuracy in distinguishing PBD patients from healthy youth.
Area of Science:
- Neuroimaging
- Child and Adolescent Psychiatry
- Biomarker Discovery
Background:
- Pediatric bipolar disorder (PBD) diagnosis relies on clinical symptoms, lacking objective biomarkers.
- Existing research suggests neuroanatomical differences in PBD, particularly in the amygdala.
Purpose of the Study:
- To investigate the utility of amygdala structural neuroanatomical signatures for objective differentiation of pediatric bipolar disorder.
- To develop and validate a predictive model for diagnosing PBD using neuroimaging data.
Main Methods:
- Acquired structural T1-weighted neuroimaging scans from 16 unmedicated children and adolescents with PBD and 16 matched healthy controls.
- Utilized voxel-based gray matter morphometric features from the amygdala.
- Developed a multivariate pattern analysis model for subject classification.
Main Results:
- The model achieved 78.12% diagnostic accuracy in classifying subjects.
- Sensitivity was 81.25%, specificity was 75.00%, with an AUC of 0.81.
- The classification accuracy was statistically significant (p = 0.0014).
Conclusions:
- Structural amygdala abnormalities are present in pediatric bipolar disorder.
- Amygdala neuroanatomical signatures can predict individual PBD status with high accuracy.
- This study presents a proof-of-concept for a neuroimaging-based diagnostic marker in medication-naïve pediatric patients.
Objectives:
Pediatric bipolar disorder is currently diagnosed based on signs and symptoms, and without objective diagnostic biomarkers. In the present study, we investigated the utility of structural neuroanatomical signatures of the amygdala to objectively differentiate individual subjects with pediatric bipolar disorder from matched healthy controls.
Methods:
Structural T1 -weighted neuroimaging scans were obtained from 16 children and adolescents with unmedicated DSM-IV bipolar disorder (11 males, five females) and 16 matched healthy controls (11 males, five females). Voxel-based gray matter morphometric features extracted from a bilateral region-of-interest within the amygdala were used to develop a multivariate pattern analysis model which was utilized in predicting novel or 'unseen' individual subjects as either bipolar disorder or healthy controls.
Results:
The model assigned 25 out of 32 subjects the correct label (bipolar disorder/healthy) translating to a 78.12% diagnostic accuracy, 81.25% sensitivity, 75.00% specificity, 76.47% positive predictive value, and 80.00% negative predictive value and an area under the receiver operating characteristic curve (ROC) of 0.81. The predictions were significant at p = 0.0014 (χ(2) test p-value).
Conclusions:
These results reaffirm previous reports on the existence of neuroanatomical abnormalities in the amygdala of pediatric patients with bipolar disorder. Remarkably, the present study also demonstrates that neuroanatomical signatures of the amygdala can predict individual subjects with bipolar disorder with a relatively high specificity and sensitivity. To the best of our knowledge, this is the first study to present a proof-of-concept diagnostic marker of pediatric bipolar disorder based on structural neuroimaging scans of largely medication-naïve patients.
More Related Videos
Related Concept Videos
Bipolar Disorder
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

